Movement Alert｜MEDBOT-B Falls 5.13% in Regular Trading, Profit-Taking Persists on High Valuation Despite Broker Initiation

Market Focus07-30

On July 30, MEDBOT-B fell 5.13% in regular trading, trading at HK$19.78/share, with turnover of HK$66.10 million. The decline extends a pattern of profit-taking following the company's positive earnings alert issued on July 22.

The sell-off continues despite DBS Vickers initiating coverage with a Buy rating and a HK$29 target price on the same day. Market analysis points to the company's price-to-sales ratio of approximately 35x, significantly above global peers such as Medtronic and Stryker, creating sustained valuation pressure. The stock had surged over 10% on July 23 and 7% on July 27 after the company forecast its first-ever half-year profit of RMB 28-40 million, reversing a RMB 115 million loss year-over-year, driven by 200-230% revenue growth and Toumai surgical robot overseas revenue surging over 450%.

The broader Health Care Equipment sector also weighed on sentiment, with MICROPORT down 4.21%, LIFETECH SCI down 2.10%, and CHUNLI MEDICAL down 2.19%, amplifying selling pressure across the segment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1158368159?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-30 13:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1158368159","market":"hk","top_or_hot":-1,"title":"Movement Alert｜MEDBOT-B Falls 5.13% in Regular Trading, Profit-Taking Persists on High Valuation Despite Broker Initiation","media":"Market Focus","content":"<p><p>On July 30, MEDBOT-B fell 5.13% in regular trading, trading at HK$19.78/share, with turnover of HK$66.10 million. The decline extends a pattern of profit-taking following the company's positive earnings alert issued on July 22.</p><p>The sell-off continues despite DBS Vickers initiating coverage with a Buy rating and a HK$29 target price on the same day. Market analysis points to the company's price-to-sales ratio of approximately 35x, significantly above global peers such as Medtronic and Stryker, creating sustained valuation pressure. The stock had surged over 10% on July 23 and 7% on July 27 after the company forecast its first-ever half-year profit of RMB 28-40 million, reversing a RMB 115 million loss year-over-year, driven by 200-230% revenue growth and Toumai surgical robot overseas revenue surging over 450%.</p><p>The broader Health Care Equipment sector also weighed on sentiment, with MICROPORT down 4.21%, LIFETECH SCI down 2.10%, and CHUNLI MEDICAL down 2.19%, amplifying selling pressure across the segment.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜MEDBOT-B Falls 5.13% in Regular Trading, Profit-Taking Persists on High Valuation Despite Broker Initiation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜MEDBOT-B Falls 5.13% in Regular Trading, Profit-Taking Persists on High Valuation Despite Broker Initiation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-30 13:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 30, MEDBOT-B fell 5.13% in regular trading, trading at HK$19.78/share, with turnover of HK$66.10 million. The decline extends a pattern of profit-taking following the company's positive earnings alert issued on July 22.</p><p>The sell-off continues despite DBS Vickers initiating coverage with a Buy rating and a HK$29 target price on the same day. Market analysis points to the company's price-to-sales ratio of approximately 35x, significantly above global peers such as Medtronic and Stryker, creating sustained valuation pressure. The stock had surged over 10% on July 23 and 7% on July 27 after the company forecast its first-ever half-year profit of RMB 28-40 million, reversing a RMB 115 million loss year-over-year, driven by 200-230% revenue growth and Toumai surgical robot overseas revenue surging over 450%.</p><p>The broader Health Care Equipment sector also weighed on sentiment, with MICROPORT down 4.21%, LIFETECH SCI down 2.10%, and CHUNLI MEDICAL down 2.19%, amplifying selling pressure across the segment.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02252","symbol_name":"微创机器人-B","start_time":0,"source_url":"","article_id":"1158368159","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1158368159","pubTimestamp":1785387872,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 30, MEDBOT-B fell 5.13% in regular trading, trading at HK$19.78/share, with turnover of HK$66.10 million. The decline extends a pattern of profit-taking following the company's positive...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02252":"微创机器人-B"},"translate_title":"走势警报|MEDBOT-B 常规交易下跌 5.13%，尽管经纪商启动，但高估值获利了结仍持续","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02252":1},"content_text":"On July 30, MEDBOT-B fell 5.13% in regular trading, trading at HK$19.78/share, with turnover of HK$66.10 million. The decline extends a pattern of profit-taking following the company's positive earnings alert issued on July 22.The sell-off continues despite DBS Vickers initiating coverage with a Buy rating and a HK$29 target price on the same day. Market analysis points to the company's price-to-sales ratio of approximately 35x, significantly above global peers such as Medtronic and Stryker, creating sustained valuation pressure. The stock had surged over 10% on July 23 and 7% on July 27 after the company forecast its first-ever half-year profit of RMB 28-40 million, reversing a RMB 115 million loss year-over-year, driven by 200-230% revenue growth and Toumai surgical robot overseas revenue surging over 450%.The broader Health Care Equipment sector also weighed on sentiment, with MICROPORT down 4.21%, LIFETECH SCI down 2.10%, and CHUNLI MEDICAL down 2.19%, amplifying selling pressure across the segment.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1158368159","isCrawlerRequest":true}